The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Sensible Biotechnologies is revolutionizing the future of mRNA therapeutics and vaccines by leveraging engineered living cells to produce high-quality, stable, and non-immunogenic mRNA in a scalable and cost-effective manner.
Sensible Biotechnologies offers competitive pricing models tailored to the needs of different clients, ensuring cost-effective access to cutting-edge mRNA technology. Contact us for detailed pricing information and custom solutions.
Our team comprises leading experts in mRNA manufacturing, synthetic biology, and life sciences, including:
Join our team of experts and contribute to the future of mRNA technology. We are hiring cell engineers, bioprocess engineers, mRNA Quality Control analysts, and RNA computational biologists for our Oxford site. Contact us to learn more about career opportunities.
Next-generation mRNA medicines
mRNA Immunotherapies to Eliminate Cancer
High quality mRNA for therapeutic application
Kernal is creating mRNA 2.0 therapies that work in specific cells
Mapping the druggable transcriptome
Next-generation mRNA platform to solve cancer, COVID and climate.
AI platform accelerating therapies for rare & inflammatory diseases.
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS